Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...

Financial framing remained anchored on the same runway and 2026 cash operating expense guidance, while Q1 2026 highlighted a "30% year-over-year reduction" in cash operating expenses and quarter-end ...

Good morning, everyone, and thank you for joining us. First, we're focusing on signal over noise, generating proof and proof points across our both wholly owned programs and our partner programs with ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported key clinical milestones across its AI-driven pipeline, including positive early data for REC-1245. The company initiated a new Phase 1 trial for ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

ADMA Biologics lowered its 2026 revenue guidance after reporting flat first-quarter sales and intensified competition in the ...

According to MarketsandMarketstm, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to USD 69.34 billion by 2031, at a CAGR of ...

DELRAY BEACH, Fla., May 8, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to USD 69.34 billion by 2031, ...

Penn researchers have developed a smarter AI method for solving notoriously difficult inverse equations, which help ...

Future AI might be programming itself ...

Langate, a software development company serving healthcare, finance, and other regulated industries, has announced the completion of a full internal AI transformation and the launch of its dedicated ...